CDK7 inhibition augments the response against multidrug chemotherapy in pancreatic cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Dissertation, 2023
- Event
-
Veröffentlichung
- (where)
-
Erlangen
- (who)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (when)
-
2023
- Creator
-
Zeng, Siyuan
- Contributor
-
Pilarsky, Christian
Pilarsky, Christian
- URN
-
urn:nbn:de:bvb:29-opus4-213327
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:46 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zeng, Siyuan
- Pilarsky, Christian
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Time of origin
- 2023
Other Objects (12)
ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer
Inhibition of ABC transporters associated with multidrug resistance
MicroRNA-146a inhibition augments angiogenesis and myocardial regeneration
Detecting drug resistance in pancreatic cancer organoids guides optimized chemotherapy treatment
Histopathological characterization of the impact of neoadjuvant chemotherapy in human pancreatic cancer
Necroptosis participates in the responsiveness of neo-adjuvant chemotherapy in pancreatic adenocarcinoma
Adjuvant chemotherapy after surgery for pancreatic ductal adenocarcinoma: retrospective real-life data
FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitro
SUMO pathway inhibition targets an aggressive pancreatic cancer subtype
[18F]FDG PET/MRI enables early chemotherapy response prediction in pancreatic ductal adenocarcinoma
Chemotherapy
Verapamil can inhibit the tumorigenicity of chemotherapy resistant side population cells in pancreatic cancer
ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer
Inhibition of ABC transporters associated with multidrug resistance
MicroRNA-146a inhibition augments angiogenesis and myocardial regeneration
Detecting drug resistance in pancreatic cancer organoids guides optimized chemotherapy treatment
Histopathological characterization of the impact of neoadjuvant chemotherapy in human pancreatic cancer
Necroptosis participates in the responsiveness of neo-adjuvant chemotherapy in pancreatic adenocarcinoma
Adjuvant chemotherapy after surgery for pancreatic ductal adenocarcinoma: retrospective real-life data
FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitro
SUMO pathway inhibition targets an aggressive pancreatic cancer subtype
[18F]FDG PET/MRI enables early chemotherapy response prediction in pancreatic ductal adenocarcinoma
Chemotherapy
Verapamil can inhibit the tumorigenicity of chemotherapy resistant side population cells in pancreatic cancer
ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer
Inhibition of ABC transporters associated with multidrug resistance
MicroRNA-146a inhibition augments angiogenesis and myocardial regeneration
Detecting drug resistance in pancreatic cancer organoids guides optimized chemotherapy treatment
Histopathological characterization of the impact of neoadjuvant chemotherapy in human pancreatic cancer
Necroptosis participates in the responsiveness of neo-adjuvant chemotherapy in pancreatic adenocarcinoma
Adjuvant chemotherapy after surgery for pancreatic ductal adenocarcinoma: retrospective real-life data
FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitro
SUMO pathway inhibition targets an aggressive pancreatic cancer subtype
[18F]FDG PET/MRI enables early chemotherapy response prediction in pancreatic ductal adenocarcinoma
Chemotherapy